Eli Lilly Teams With Express Scripts to Offer Discounted Insulin

Shares of Eli Lilly were higher Tuesday after announcing that starting January of 2017, customers will be able to purchase insulin at a discount of up to 40%.

Author:: Valerie Young
Publish date:: Dec 13, 2016 12:35 PM EST

Shares of Eli Lilly (LLY) - Get Report were higher Tuesday after the drug manufacturing company announced that starting January first of next year, customers will be able to purchase insulin at a discount of up to 40% amid a partnership with Express Scripts (ESRX) . The deal is intended to help people who have no insurance or high deductible plans. Users can use the Blink Health online pharmacy platform to activate the discounts. The vice president of Lilly Diabetes, said that, "this platform will effectively allow Lilly to lower our insulin retail prices for users of this platform while not affecting the reimbursement system for other people living with diabetes." TheStreet's Alicia McElhaney highlights that Eli Lilly's pricing change comes amid the backlash Mylan (MYL) - Get Reportfaced, when it hiked its EpiPen drug earlier this year.